Domenic C. Izzo, Jr., MD, of Berks Eye Physicians And Surgeons, Ltd, Introduces Lipiflow® Treatment to Address Dry Eye Caused By Meibomian Gland Dysfunction

Share Article

Domenic C. Izzo, Jr., MD, of Berks Eye Physicians and Surgeons, LTD, introduces LipiFlow treatment to address dry eye caused by meibomian gland dysfunction.

Normal vs. MGD Comparison

LipiFlow is safe and the most effective treatment for MGD available today.”

Domenic C. Izzo, Jr., MD, of Berks Eye Physicians & Surgeons Ltd., a full-service medical and surgical eye care center, today announced he is now providing a revolutionary new treatment, LipiFlow®, for patients who suffer from dry eye caused by Meibomian Gland Dysfunction (MGD). MGD, a progressive disease that affects some 300 million people worldwide, stems from blockages in the oil-producing Meibomian glands located in the eyelids. LipiFlow unlocks the glands to resume the secretion of oily lipids needed for healthy tear film.

Developed as a result of 30 years of scientific research, LipiFlow® is an in-office procedure that uses directed heat and gentle pressure to liquefy and express the contents of meibomian glands. This revolutionary treatment is FDA-cleared and scientifically proven. In a clinical study, 90 percent of patients achieved improvements in gland secretions after a single LipiFlow treatment.

MGD can negatively impact long-term vision and ocular health. If left untreated, MGD will worsen over time, leading to eye redness, dryness, irritation, burning, fluctuating vision, and eye fatigue. These symptoms can hinder daily activities such as reading, using the computer, wearing contact lenses, and being outdoors on windy days. MGD is thought to be present in 86% of people with dry eyes.

Patients who suffer from these symptoms should be screened for MGD as part of their routine comprehensive eye examination. Patients considering cataract surgery and refractive surgery such as LASIK should be screened for dry eye and MGD as well. Early identification and treatment of MGD can yield the best results for long-term ocular health as well as the best possible eye surgical outcomes.

“Dry eye disease is one of the most common chief complaints that I hear from patients,” said Domenic C. Izzo, Jr., MD, cataract surgery and LASIK surgery specialist at Berks Eye Physicians and Surgeons. “I am pleased to introduce LipiFlow for my patients who are frustrated with all the ways that MGD negatively impacts their lives. Conventional therapies, such as warm compresses, over- the-counter wetting drops, ointments, and prescription drugs alone often have failed to provide the relief that LipiFlow offers. LipiFlow is safe and the most effective treatment for MGD available today.”

About Dr. Izzo:
For over 30 years, Dr. Izzo has provided comprehensive eye care, with a focus on cataract and lens implant surgery, including advanced technology intraocular lenses, as well as corneal refractive surgery including LASIK. He utilizes the latest diagnostic testing, medications, laser treatments and surgical procedures and is recognized for exceptional skill and experience. Dr. Izzo specializes in Cataract Surgery, Glaucoma Management, Laser Vision Correction (LASIK), and Dry Eye Treatment, in addition to providing comprehensive eye examinations. He can be reached at Berks Eye Physicians and Surgeons at 1802 paper Mill Road, Wyomissing, PA and at 610-372-0712.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website